21704-46-1 Usage
Uses
Used in Agricultural Industry:
Ethyl carbamimidothioate-diethyl hydrogen phosphate (1:1) is used as a pesticide and herbicide for the purpose of protecting crops from a variety of pests and weeds, thereby enhancing crop yield and quality.
Used in Chemical Production:
ethyl carbamimidothioate-diethyl hydrogen phosphate (1:1) is utilized as a precursor or intermediate in the synthesis of other chemical compounds, contributing to the development of new products in the chemical industry.
Used in Solvent Applications:
Due to the properties of diethyl hydrogen phosphate, the compound may also be employed as a solvent in various industrial processes where its unique characteristics are beneficial.
Used in Flame Retardant Production:
Given the use of diethyl hydrogen phosphate in the creation of flame retardants, ethyl carbamimidothioate-diethyl hydrogen phosphate (1:1) could potentially be integrated into the formulation of flame retardant products to enhance their performance and safety.
Check Digit Verification of cas no
The CAS Registry Mumber 21704-46-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,1,7,0 and 4 respectively; the second part has 2 digits, 4 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 21704-46:
(7*2)+(6*1)+(5*7)+(4*0)+(3*4)+(2*4)+(1*6)=81
81 % 10 = 1
So 21704-46-1 is a valid CAS Registry Number.
21704-46-1Relevant academic research and scientific papers
Pharmaceutical compositions for headache, migraine, nausea and emesis
-
, (2008/06/13)
S-alkylsiothiouronium derivatives such as S-ethylisothiouronium diethylphosphate are used for the treatment of headaches, in particular, migraines, as well as for the prevention or treatment of nausea and vomiting. The compositions of the invention are also effective in preventing or alleviating emesis associated with migraines or other medical conditions such as chemotherapy or radiotherapy, as well as other symptoms of migraines including phonophobia and photophobia.
Pharmaceutical compositions comprising S-alkylisothiouronium derivatives
-
, (2008/06/13)
PCT No. PCT/IL97/00314 Sec. 371 Date Jun. 9, 1999 Sec. 102(e) Date Jun. 9, 1999 PCT Filed Sep. 25, 1997 PCT Pub. No. WO98/13036 PCT Pub. Date Apr. 2, 1998S-Alkylisothiouronium salts with phosphorus-containing acids are described. The compounds are used in processes of treating acute hypotension, which may result, for example, from shock or hemorrhage, and in processes for treating hyperoxic conditions, for example, oxygen poisoning.
